Skip to main content
. 2021 Oct 29;28(2):178–189. doi: 10.1016/j.cmi.2021.10.015

Table 1.

Numbers of asymptomatic and presymptomatic cases at the time of testing and infectious statusa

Study Asymptomatic at the time of testing, n/N (%) Asymptomatic infectious, n/N (%) Presymptomatic infectious, n/N (%) Population/setting
Arons 27/48 (56.3) 1/3 (33.3) 17/24 (70.8) Skilled nursing home facility
Borges 39/48 (81.3) N/A N/A Non-COVID-19 hospital ward
Cordery 3/13 (23.1) No viral growth Children and young people in school settings
De Laval 3/24 (12.5) N/A N/A Military support facility cases and contacts
Ferreria N/A N/A N/A Healthcare workers
Gettings 30/139 (21.6) N/A N/A Students and staff in school
Hershow 18/56 (32.1) N/A N/A Students and staff in elementary schools
Jeffery Smith 16/16 (100) N/A N/A Care home
Lewis 2/12 (16.7) N/A No culturable and potentially infectious virus could be isolated Households
Murata 90/90 (100) 7/39 (17.9) Passengers disembarking from the Diamond Princess cruise ship
Pray 7/39 (17.9) 6/32 (18.8) University campus
Soto 8/30 (26.7) N/A N/A Emergency childcare centre contacts
Speake 22/29 (75.9) 4/11 (36.4) N/A Passengers on a flight
Surie 11/17 (65) One participant became symptomatic on day 3 after the first possible (RT-PCR positive) test and was culture-positive on the day of the initial test. One severely immunocompromised participant shed replication-competent virus for 19 days from the positive test (17 days from symptom onset)b Nursing home residents
Taylor 17/24 (70.8) 6/7 (85.7) Army barracks
Van Hensbergen 3/19 (15.8)c N/A N/A Long-term care facility
Wallace 49/111 (44.1) 12/52 (23.1) 2/3 (66.7) Detainees in a detention centre

N/A = culture not attempted.

a

The studies report replicating SARS-CoV-2 from viral culture.

b

Data in Fig. 1 in the paper identifies the immunocompromised patient as participant Q and the individual who became symptomatic on day 3 as participant K.

c

Asymptomatic (potentially presymptomatic).